Eric Bergeron (B.Eng., M.Sc.A, Ph.D.)
Eric Bergeron (B.Eng., M.Sc.A, Ph.D.)
Dawson College
Verified email at
Cited by
Cited by
Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
H Senta, H Park, E Bergeron, O Drevelle, D Fong, E Leblanc, F Cabana, ...
Cytokine & Growth Factor Reviews 20 (3), 213-222, 2009
BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment
E Leblanc, F Trensz, S Haroun, G Drouin, É Bergeron, CM Penton, ...
Journal of Bone and Mineral Research 26 (6), 1166-1177, 2011
Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres
E Bergeron, ME Marquis, I Chretien, N Faucheux
Journal of Materials Science: Materials in Medicine 18 (2), 255-263, 2007
Bone cells-biomaterials interactions
ME Marquis, E Lord, E Bergeron, O Drevelle, H Park, F Cabana, H Senta, ...
Frontiers in Bioscience 14 (3), 1023-1067, 2009
Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9
E Bergeron, H Senta, A Mailloux, H Park, E Lord, N Faucheux
Tissue Engineering Part A 15 (11), 3341-3349, 2009
Bone repair: New developments in growth factor delivery systems and their mathematical modeling
MA Lauzon, É Bergeron, B Marcos, N Faucheux
Journal of Controlled Release 162 (3), 502-520, 2012
Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways
H Park, E Bergeron, H Senta, K Guillemette, S Beauvais, R Blouin, ...
Biochemical and Biophysical Research Communications 399 (3), 446-451, 2010
Hyperspectral reflected light microscopy of plasmonic Au/Ag alloy nanoparticles incubated as multiplex chromatic biomarkers with cancer cells
S Patskovsky, E Bergeron, D Rioux, M Simard, M Meunier
Analyst 139 (20), 5247–5253, 2014
The evaluation of ectopic bone formation induced by delivery systems for bone morphogenetic protein-9 or its derived peptide
E Bergeron, E Leblanc, O Drevelle, R Giguère, S Beauvais, G Grenier, ...
Tissue Engineering Part A 18 (3-4), 342-352, 2012
Gold nanoparticle-assisted all optical localized stimulation and monitoring of Ca2+ signaling in neurons
F Lavoie-Cardinal, C Salesse, E Bergeron, M Meunier, P De Koninck
Scientific Reports 6, 20619, 2016
Wide‐field hyperspectral 3D imaging of functionalized gold nanoparticles targeting cancer cells by reflected light microscopy
S Patskovsky, E Bergeron, D Rioux, M Meunier
Journal of Biophotonics 8 (5), 401-407, 2015
Hyperspectral darkfield microscopy of PEGylated gold nanoparticles targeting CD44‐expressing cancer cells
S Patskovsky, E Bergeron, M Meunier
Journal of Biophotonics 8 (1-2), 162-167, 2015
Effect of functionalized polycaprolactone on the behaviour of murine preosteoblasts
O Drevelle, E Bergeron, H Senta, MA Lauzon, S Roux, G Grenier, ...
Biomaterials 31 (25), 6468-6476, 2010
Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles
E Bergeron, C Boutopoulos, R Martel, A Torres, C Rodriguez, J Niskanen, ...
Nanoscale 7 (42), 17836-17847, 2015
Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9
ME Marquis, E Lord, E Bergeron, L Bourgoin, N Faucheux
Biomaterials 29 (8), 1005-1016, 2008
Cell perforation mediated by plasmonic bubbles generated by a single near infrared femtosecond laser pulse
C Boutopoulos, E Bergeron, M Meunier
Journal of Biophotonics 9 (1-2), 26-31, 2016
Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes
E Lord, E Bergeron, H Senta, H Park, N Faucheux
Growth Factors 28 (3), 149-156, 2010
Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach
D Hubmacher, E Bergeron, C Fagotto-Kaufmann, LY Sakai, DP Reinhardt
Biomacromolecules 15 (4), 1456-1468, 2014
Combination of synthetic peptides derived from bone morphogenetic proteins and biomaterials for medical applications
H Senta, E Bergeron, O Drevelle, H Park, N Faucheux
The Canadian Journal of Chemical Engineering 89 (2), 227-239, 2011
Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9
H Park, O Drevelle, A Daviau, H Senta, E Bergeron, N Faucheux
Anti-Cancer Drugs 24 (3), 278-290, 2013
The system can't perform the operation now. Try again later.
Articles 1–20